Literature DB >> 10820378

BLNK is associated with the CD72/SHP-1/Grb2 complex in the WEHI231 cell line after membrane IgM cross-linking.

N Fusaki1, S Tomita, Y Wu, N Okamoto, R Goitsuka, D Kitamura, N Hozumi.   

Abstract

Tyrosine phosphorylation of CD72 strongly correlates with B cell antigen receptor signals leading to apoptosis. We have previously shown that CD72 carrying two immunoreceptor tyrosine-based inhibition motifs (ITIM) is an in vivo substrate of SHP-1. CD72 forms a complex with SHP-1 and Grb2 via its tyrosine-phosphorylated ITIM when the WEHI231 cell line, which is representative of immature B cells, undergoes apoptosis. The CD72 complex formation was also demonstrated in normal primary B cells, suggesting that the complex formation in apoptotic B cells is a universal mechanism. In this study, we further investigated the molecular components of the CD72 complex in WEHI231 cells in order to understand the molecular mechanism involved in the signaling pathway mediated through the complex. Our experiments demonstrate that BLNK, a recently identified adaptor molecule predominantly expressed in B cells, is associated with the CD72 complex via the Src homology 3 domain(s) of Grb2 in the cell line after membrane IgM (mIgM) engagement. The results suggest that the mIgM-mediated signal strongly correlates with the formation of the CD72 / SHP-1 / Grb2 / BLNK complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820378     DOI: 10.1002/(SICI)1521-4141(200005)30:5<1326::AID-IMMU1326>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Positive and negative roles of CD72 in B cell function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  A Comprehensive Immunoreceptor Phosphotyrosine-based Signaling Network Revealed by Reciprocal Protein-Peptide Array Screening.

Authors:  Huadong Liu; Lei Li; Courtney Voss; Feng Wang; Juewen Liu; Shawn Shun-Cheng Li
Journal:  Mol Cell Proteomics       Date:  2015-04-23       Impact factor: 5.911

3.  Development of SH2 probes and pull-down assays to detect pathogen-induced, site-specific tyrosine phosphorylation of the TLR adaptor SCIMP.

Authors:  Lin Luo; Samuel J Tong; Adam A Wall; Tatiana Khromykh; Matthew J Sweet; Jennifer L Stow
Journal:  Immunol Cell Biol       Date:  2017-03-14       Impact factor: 5.126

Review 4.  Biology and function of neuroimmune semaphorins 4A and 4D.

Authors:  EusebiusHenry Nkyimbeng-Takwi; Svetlana P Chapoval
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

5.  Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.

Authors:  T Oka; T Yoshino; K Hayashi; N Ohara; T Nakanishi; Y Yamaai; A Hiraki; C A Sogawa; E Kondo; N Teramoto; K Takahashi; J Tsuchiyama; T Akagi
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures.

Authors:  Andrea Zangrando; Marta Campo Dell'orto; Geertruy Te Kronnie; Giuseppe Basso
Journal:  BMC Med Genomics       Date:  2009-06-23       Impact factor: 3.063

Review 7.  B-cell antigen-receptor signalling in lymphocyte development.

Authors:  Leo D Wang; Marcus R Clark
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

8.  CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.542

9.  A regulatory role for CD72 expression on B cells and increased soluble CD72 in primary Sjogren's syndrome.

Authors:  Yuqi Shen; Yuhua Ma; Jingyuan Xie; Li Lin; Yifan Shi; Xiao Li; Pingyan Shen; Xiaoxia Pan; Hong Ren
Journal:  BMC Immunol       Date:  2020-04-19       Impact factor: 3.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.